Pomalidomide as an Immune-enhancing Agent for the Control of HIV

NCT06660498 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: Pomalidomide 2 mg
DRUG: Placebo
DRUG: Aspirin 75 mg

Sponsor

University of Aarhus